Breast Cancer
-
First Immunotherapy Approved for Breast CancerMedical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
by Anna Azvolinsky
-
Considering the Term “Cancer Survivor”A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
-
Treating Breast Cancer in MenHormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women.
by Marilyn Fenichel
-
Survivor Profile
The Bridge BuilderBreast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
-
The Education of a Patient AdvocateBob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
-
2018 SABCS: Choosing the Right TreatmentStudies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
by Kate Yandell
-
Guiding CareMedical oncologist Gabrielle Rocque explains the role of clinical practice guidelines in breast cancer care.
by Anna Azvolinsky
-
Does Medicaid Expansion Have an Impact?Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
by Marci A. Landsmann
-
Palliative Care Pays OffPatients with advanced cancer who receive palliative care tend to live longer and have better quality of life than those who do not receive this care.
by Cheryl Platzman Weinstock
-
Raising Their VoicesPeople with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
